SynthesisBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review.

Rosanne W Meijboom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.